OMC
53
3
HST
40
2
CHK
5
-7
VLO
33
-5
ALL
45
-3
EXPE
66
2
EXC
47
2
HSIC
44
4
TXN
33
3
TROW
48
-2
RIG
28
2
KHC
29
2
NWS
77
8
HAL
41
11
MLM
63
2
EQIX
50
3
PVH
63
5
MRK
66
3
LLY
73
-3
C
37
-2
OMC
53
3
HST
40
2
CHK
5
-7
VLO
33
-5
ALL
45
-3
EXPE
66
2
EXC
47
2
HSIC
44
4
TXN
33
3
TROW
48
-2
RIG
28
2
KHC
29
2
NWS
77
8
HAL
41
11
MLM
63
2
EQIX
50
3
PVH
63
5
MRK
66
3
LLY
73
-3
C
37
-2
Financhill
Back

Innovate Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
40

VATE
Innovate

Last Price:
0.62
Seasonality Move:
-12.64%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
40
Innovate (VATE) is a Sell

Is Innovate a Buy, Sell or Hold?

  • The current Innovate [VATE] share price is $0.65. The Score for VATE is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VATE Stock Price Chart

What is Innovate's stock price today?

  • The Innovate share price today is $0.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VATE is experiencing buying pressure, which is a positive indicator for future bullish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

VATE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 51.27 Buy
Chaikin Money Flow: 368686 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.59 - 0.71) Buy
Bollinger Bands (100): (0.61 - 0.85) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

VATE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.61 Buy
20-day SMA: 0.62 Buy
50-day SMA: 0.66 Sell
200-day SMA: 0.99 Sell
8-day EMA: 0.62 Buy
20-day EMA: 0.63 Buy
50-day EMA: 0.67 Sell
200-day EMA: 1 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Innovate Earnings Growth & VATE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Innovate Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):